This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Morgan Stanley leads Subtle Medical financing
Business growth financing

Morgan Stanley leads Subtle Medical financing

Analysis based on 10 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026

Sentiment
60
Attention
4
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The $33 million growth financing for Subtle Medical>>> is expected to positively impact the healthcare technology market by accelerating the development and commercial expansion of AI-powered medical imaging solutions. This investment signals strong investor confidence in the sector and could lead to increased adoption of software-based infrastructure in healthcare, potentially benefiting other companies in the medical imaging and AI space.

Healthcare Technology Venture Capital Medical Imaging
Event Summary

Morgan Stanley — Morgan Stanley Expansion Capital>>>, a part of Morgan Stanley>>> Investment Management, led a $33 million growth financing round for Subtle Medical>>>, an AI-powered medical imaging software company. This funding, which also saw participation from Ono Venture Investment>>>, Fusion Fund>>>, EnvisionX>>>, Brazilian real>>>, and Samsung — Samsung Ventures>>>, brings Subtle Medical>>>'s total capital raised to $86 million. The financing is intended to support Subtle Medical>>>'s continued product development and commercial expansion across the United States and international markets. Subtle Medical>>> develops vendor-neutral software to improve imaging workflow efficiency and image quality across MRI, PET, and CT, with 11 FDA-cleared products deployed on over 1,300 scanners globally. The company's CEO, Ohad Arazi>>>, highlighted the importance of this capital and partnership for accelerating global adoption.

Entities Involved
priv
Subtle Medical
Subtle Medical received $33 million in growth financing, led by Morgan Stanley — Morgan Stanley Expansion Capital>>>, to support its product development and commercial expansion. This funding brings its total capital raised to $86 million, enhancing its ability to deploy AI-powered medical imaging solutions globally.
Importance 100.0 Sentiment 70.0
subs
Morgan Stanley — Morgan Stanley Expansion Capital
Morgan Stanley — Morgan Stanley Expansion Capital>>>, a growth-focused private investment platform within Morgan Stanley>>> Investment Management, led the $33 million financing round for Subtle Medical>>>. This action highlights its role in supporting late-stage growth equity in healthcare technology.
Importance 90.0 Sentiment 30.0
stock
Morgan Stanley
Morgan Stanley>>>'s investment management arm, through Morgan Stanley — Morgan Stanley Expansion Capital>>>, led the $33 million growth financing for Subtle Medical>>>, demonstrating its strategic interest in healthcare technology and AI. This investment expands Morgan Stanley>>>'s portfolio in high-growth sectors.
Importance 80.0 Sentiment 20.0
priv
Ono Venture Investment
Ono Venture Investment>>> participated in the $33 million growth financing for Subtle Medical>>>, contributing to the total capital raised. This investment aligns with its focus on early-to-growth stage investments in technology and healthcare.
Importance 50.0 Sentiment 10.0
stock
Mizuho Financial Group
Mizuho Financial Group>>> is the parent company of Ono Venture Investment>>>, which participated in the financing round for Subtle Medical>>>. This involvement reflects Mizuho Financial Group>>>'s broader financial network supporting high-growth sectors.
Importance 30.0 Sentiment 5.0
oth
Fusion Fund
Fusion Fund>>> is an existing investor in Subtle Medical>>> and participated in the latest $33 million growth financing round, continuing its support for the medical imaging software company.
Importance 20.0 Sentiment 5.0
priv
EnvisionX
EnvisionX>>> is an existing investor in Subtle Medical>>> and participated in the latest $33 million growth financing round, showing continued confidence in the company's growth.
Importance 20.0 Sentiment 5.0
oth
Brazilian real
Brazilian real>>> is an existing investor in Subtle Medical>>> and participated in the latest $33 million growth financing round, maintaining its investment in the AI-powered medical imaging sector.
Importance 20.0 Sentiment 5.0
subs
Samsung — Samsung Ventures
Samsung — Samsung Ventures>>> is an existing investor in Subtle Medical>>> and participated in the latest $33 million growth financing round, reinforcing its commitment to innovative technology companies.
Importance 20.0 Sentiment 5.0
per
Kevin Han
Kevin Han>>>, Executive Director at Morgan Stanley — Morgan Stanley Expansion Capital>>>, provided commentary on the investment, highlighting Subtle Medical>>>'s market need and potential. His role is primarily as a spokesperson for the lead investor.
Importance 10.0 Sentiment 0.0
per
Ohad Arazi
Ohad Arazi>>>, the newly appointed CEO of Subtle Medical>>>, expressed enthusiasm for the financing and partnership with Morgan Stanley — Morgan Stanley Expansion Capital>>>, emphasizing the capital's role in accelerating global expansion.
Importance 10.0 Sentiment 0.0
Relationships
Morgan Stanley related ↔ Mizuho Financial Group
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.